Table S3. DEGs for unadjusted gene expression. DEGs at FDR ≤ 0.05 in DCM vs NF and ICM vs NF. (XLSX 568 kb
Polysome-bound and ribosome-free RNA-seq data of D0 vs. D15 comparison (FDR < 0.05). (XLSX 3849 kb
Ribosome-free RNA-seq data of comparisons of each sample against the preceding time-point (FDR < 0.0...
IntroductionHeart failure (HF) is a complex clinical syndrome leading to high morbidity. In this stu...
Figure S1. Empirical distribution of FDR values â¤0.05 for 1000 permutations. Histogram with the nu...
Figure S2. Disease-specific DEGs clusters samples by phenotype in publicly available expression data...
Table S7. Predicted biofunctions. IPA biofunctions predicted to be increased or decreased for Analys...
Table S5. Enriched IPA Canonical Pathways. IPA canonical pathways for p ≤ 0.05 for Analysis 1 (HF-DE...
Table S1. Sample table. Characteristics including sex, race, ethnicity, age, cause of death (if appl...
Table S6. Enriched IPA Toxicity. IPA toxicity lists for p ≤ 0.05 for Analysis 1 (HF-DEGs). (XLSX 15 ...
Table S2. RNAseq quality control table. Raw read counts ranged from ~â36 to 66 million. Read count...
Abstract Background Current heart failure (HF) treatment is based on targeting symptoms and left ven...
Overlapping genes among significant pathways for hearf failure before data processing. (PDF 145Â kb
Polysome-bound RNA-seq data of comparisons of each sample against the preceding time-point (FDR < 0....
ObjectivesThis study was designed to identify a common gene expression signature in dilated cardiomy...
Figure S3. Manhattan Plot of the gene-wise analysis of heart rate. Blue reference line: 1x10-5, Red ...
Polysome-bound and ribosome-free RNA-seq data of D0 vs. D15 comparison (FDR < 0.05). (XLSX 3849 kb
Ribosome-free RNA-seq data of comparisons of each sample against the preceding time-point (FDR < 0.0...
IntroductionHeart failure (HF) is a complex clinical syndrome leading to high morbidity. In this stu...
Figure S1. Empirical distribution of FDR values â¤0.05 for 1000 permutations. Histogram with the nu...
Figure S2. Disease-specific DEGs clusters samples by phenotype in publicly available expression data...
Table S7. Predicted biofunctions. IPA biofunctions predicted to be increased or decreased for Analys...
Table S5. Enriched IPA Canonical Pathways. IPA canonical pathways for p ≤ 0.05 for Analysis 1 (HF-DE...
Table S1. Sample table. Characteristics including sex, race, ethnicity, age, cause of death (if appl...
Table S6. Enriched IPA Toxicity. IPA toxicity lists for p ≤ 0.05 for Analysis 1 (HF-DEGs). (XLSX 15 ...
Table S2. RNAseq quality control table. Raw read counts ranged from ~â36 to 66 million. Read count...
Abstract Background Current heart failure (HF) treatment is based on targeting symptoms and left ven...
Overlapping genes among significant pathways for hearf failure before data processing. (PDF 145Â kb
Polysome-bound RNA-seq data of comparisons of each sample against the preceding time-point (FDR < 0....
ObjectivesThis study was designed to identify a common gene expression signature in dilated cardiomy...
Figure S3. Manhattan Plot of the gene-wise analysis of heart rate. Blue reference line: 1x10-5, Red ...
Polysome-bound and ribosome-free RNA-seq data of D0 vs. D15 comparison (FDR < 0.05). (XLSX 3849 kb
Ribosome-free RNA-seq data of comparisons of each sample against the preceding time-point (FDR < 0.0...
IntroductionHeart failure (HF) is a complex clinical syndrome leading to high morbidity. In this stu...